Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

Background: Myeloma causes profound immunodeficiency and recurrent serious infections. There are approximately 5500 new UK cases of myeloma per annum, and one-quarter of patients will have a serious infection within 3 months of diagnosis. Newly diagnosed patients may benefit from antibiotic prophyla...

Full description

Bibliographic Details
Main Authors: Mark T Drayson, Stella Bowcock, Tim Planche, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Helen Higgins, Bryony Dawkins, David Meads, Claire T Hulme, Anna C Whittaker, Peter Hawkey, Eric Low, Janet A Dunn
Format: Article
Language:English
Published: NIHR Journals Library 2019-11-01
Series:Health Technology Assessment
Subjects:
myeloma
antibiotic prophylaxis
health-care-associated infections
survival
infection
Online Access:https://doi.org/10.3310/hta23620

Internet

https://doi.org/10.3310/hta23620

Similar Items